Track the 유한양행 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 유한양행 has logged 111 insider filings. Market capitalisation: €6,197.9bn. The latest transaction was filed on 2 July 2026 (Purchase). Among the most active insiders: 김열홍. Every trade is openly available.
108
Insider Decl.
n/a
Thresholds
€195m
95 ops.
Buy Volume
n/a
7 ops.
Sell Volume
41Σ signal
Buys €195mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,023 of 29,281 companies
49.4
score / 100
Value
39
Quality
60
FCF yld-0.7%
Earn yld3.6%
EV/EBITDA18.9x
ROE9.5%
Gross mgn33%
Net mgn8.9%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
500 shares@ ₩93,974.000.0007% mcap100.0% of flowShareKRXDART:20260414002426
25 of 111 declarations
About 유한양행
Yuhan Corporation is a South Korean pharmaceutical company engaged in the research, development, and manufacturing of drugs. It is listed on the Korea Exchange, XKRX.